Viral infections in human immunodeficiency virus disease (Q41418360)

30 September 2017

1 reference

title

Viral infections in human immunodeficiency virus disease (English)

1 reference

30 September 2017

Cavert W

1

1 reference

30 September 2017

publication date

1 March 1997

1 reference

Medical Clinics of North America

30 September 2017

published in

1 reference

30 September 2017

volume

81

1 reference

30 September 2017

issue

2

1 reference

30 September 2017

page(s)

411-426

1 reference

Inability of Enzyme Immunoassays to Discriminate between Infections with Herpes Simplex Virus Types 1 and 2

30 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970524-1

Increased genital shedding of herpes simplex virus type 2 in HIV-seropositive women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970524-1

Relationship between herpes simplex virus ulceration and CD4+ cell counts in patients with HIV infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970524-1

Valaciclovir compared with acyclovir for improved therapy for herpes zoster in immunocompetent adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970524-1

Treatment of AIDS-Associated Gastrointestinal Cytomegalovirus Infection with Foscarnet and Ganciclovir: A Randomized Comparison

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970524-1

Bronchoalveolar lavage and transbronchial biopsy for the diagnosis of pulmonary infections in the acquired immunodeficiency syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970524-1

Herpes Zoster and Human Immunodeficiency Virus Infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970524-1

Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970524-1

Infection due to parvovirus B19 in patients infected with human immunodeficiency virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970524-1

Cytomegalovirus infection in homosexual men. Relationship to sexual practices, antibody to human immunodeficiency virus, and cell-mediated immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970524-1

Human herpesvirus 6 and pneumonia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970524-1

Oesophageal symptoms, their causes, treatment, and prognosis in patients with the acquired immunodeficiency syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970524-1

Infections with herpes simplex viruses (1).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970524-1

Ganciclovir treatment of cytomegalovirus colitis in AIDS: a randomized, double-blind, placebo-controlled multicenter study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970524-1

Herpes simplex virus type 2 encephalitis in two homosexual men with persistent lymphadenopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970524-1

A Double-Blind Study of Oral Acyclovir for Suppression of Recurrences of Genital Herpes Simplex Virus Infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970524-1

Oral ganciclovir as maintenance treatment for cytomegalovirus retinitis in patients with AIDS. Syntex Cooperative Oral Ganciclovir Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970524-1

Acyclovir-resistant herpes simplex virus infections in patients with the acquired immunodeficiency syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970524-1

Recurrence and resistance patterns of herpes simplex virus following cessation of > or = 6 years of chronic suppression with acyclovir. Acyclovir Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970524-1

Detection of herpesvirus DNA by nested polymerase chain reaction in cerebrospinal fluid of human immunodeficiency virus-infected persons with neurologic disease: a prospective evaluation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970524-1

Lack of association between acyclovir use and survival in patients with advanced human immunodeficiency virus disease treated with zidovudine. Zidovudine Epidemiology Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970524-1

Herpes simplex virus type 2 meningoencephalitis resistant to acyclovir in a patient with AIDS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970524-1

A cross-sectional study of herpes simplex virus types 1 and 2 in college students: occurrence and determinants of infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970524-1

Herpes simplex virus proctitis in homosexual men. Clinical, sigmoidoscopic, and histopathological features

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970524-1

Replication of Epstein-Barr virus within the epithelial cells of oral "hairy" leukoplakia, an AIDS-associated lesion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970524-1

Herpes simplex virus infection as a risk factor for human immunodeficiency virus infection in heterosexuals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970524-1

Clinical manifestations of AIDS in the era of pneumocystis prophylaxis. Multicenter AIDS Cohort Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970524-1

Acyclovir-resistant varicella zoster virus infection after chronic oral acyclovir therapy in patients with the acquired immunodeficiency syndrome (AIDS).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970524-1

Serious cytomegalovirus disease in the acquired immunodeficiency syndrome (AIDS). Clinical findings, diagnosis, and treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970524-1

Primary central nervous system lymphomas--new pathological developments

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970524-1

Comparison of intramuscular recombinant alpha interferon (rIFN-2A) with topical acyclovir for the treatment of first-episode herpes genitalis and prevention of recurrences

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970524-1

Human herpesvirus 6 in AIDS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970524-1

Treatment of cytomegalovirus retinitis with an intraocular sustained-release ganciclovir implant. A randomized controlled clinical trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970524-1

JC virus DNA in cerebrospinal fluid of human immunodeficiency virus-infected patients: predictive value for progressive multifocal leukoencephalopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970524-1

Dosage and safety of long-term suppressive acyclovir therapy for recurrent genital herpes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970524-1

Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma in patients with and without HIV infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970524-1

Long-term remission of Kaposi's sarcoma following foscarnet treatment in HIV-infected patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970524-1

Detection of a Herpes Simplex Viral Antigen in Skin Lesions of Erythema Multiforme

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970524-1

Famciclovir. A review of its pharmacological properties and therapeutic efficacy in herpesvirus infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970524-1

Herpesvirus Infections in the Acquired Immune Deficiency Syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970524-1

Management of persistent B19 parvovirus infection in AIDS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970524-1

Cytomegalovirus multifocal neuropathy in AIDS: analysis of 15 consecutive cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970524-1

Clinical and serologic features of herpes simplex virus infection in patients with AIDS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970524-1

Foscarnet therapy for acyclovir-resistant mucocutaneous herpes simplex virus infection in 26 AIDS patients: preliminary data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970524-1

Foscarnet Therapy in Five Patients with AIDS and Acyclovir-resistant Varicella-Zoster Virus Infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970524-1

A controlled trial comparing foscarnet with vidarabine for acyclovir-resistant mucocutaneous herpes simplex in the acquired immunodeficiency syndrome. The AIDS Clinical Trials Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970524-1

Foscarnet-resistant herpes simplex virus infection in patients with AIDS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970524-1

Oral acyclovir therapy for mucocutaneous herpes simplex virus infections in immunocompromised marrow transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970524-1

Severe Acquired Immunodeficiency in Male Homosexuals, Manifested by Chronic Perianal Ulcerative Herpes Simplex Lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970524-1

Oral ganciclovir for the prevention of cytomegalovirus disease in persons with AIDS. Roche Cooperative Oral Ganciclovir Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970524-1

Severe cytomegalovirus pneumonitis in HIV infected patients with higher than average CD4 counts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970524-1

Herpesvirus infections in persons infected with human immunodeficiency virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970524-1

Acyclovir suppression of frequently recurring genital herpes. Efficacy and diminishing need during successive years of treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970524-1

Effect of oral acyclovir treatment on symptomatic and asymptomatic virus shedding in recurrent genital herpes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970524-1

Acyclovir for chronic mucocutaneous herpes simplex virus infection in immunosuppressed patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970524-1

Mortality in patients with the acquired immunodeficiency syndrome treated with either foscarnet or ganciclovir for cytomegalovirus retinitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970524-1

Cytomegalovirus infection of the alimentary canal: radiologic findings with pathologic correlation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970524-1

Immunohistochemical detection of an immediate early antigen of human cytomegalovirus in normal tissues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970524-1

Famciclovir for the Treatment of Acute Herpes Zoster: Effects on Acute Disease and Postherpetic Neuralgia: A Randomized, Double-Blind, Placebo-Controlled Trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970524-1

Human papillomavirus infection and associated disease in persons infected with human immunodeficiency virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970524-1

Pharmacokinetics of the acyclovir pro-drug valaciclovir after escalating single- and multiple-dose administration to normal volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970524-1

Episodic acyclovir therapy to abort recurrent attacks of genital herpes simplex infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970524-1

Vidarabine versus acyclovir therapy in herpes simplex encephalitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970524-1

Vidarabine therapy for mucocutaneous herpes simplex virus infections in the immunocompromised host

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970524-1

Acyclovir with and without prednisone for the treatment of herpes zoster. A randomized, placebo-controlled trial. The National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970524-1

Cytomegalovirus esophagitis in patients with AIDS. A clinical, endoscopic, and pathologic correlation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970524-1

Esophageal ulceration in human immunodeficiency virus infection. Causes, response to therapy, and long-term outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970524-1

10.1016/S0025-7125(05)70524-1

7 January 2021

Identifiers

DOI

1 reference

30 September 2017

1 reference